Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation sequencing in hypoplastic bone marrow failure: What difference does it make?

European journal of haematology - 1 Jan 2021

Skibenes Sofie T, Clausen Ida, Raaschou-Jensen Klas

Abstract excerpt

Hypoplastic bone marrow failure is a diagnostic feature of multiple haematological disorders, which also share a substantial overlap of clinical symptoms. Hence, discrimination of underlying disorders in patients presenting with hypoplastic bone marrow failure remains a major challenge in the clinic. Recent next-generation sequencing (NGS) studies have broadened our understanding of the varying molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Biopsy
Share to Bone Marrow

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow Failure Disorders

Share to Diagnosis, Differential

Share to Disease Susceptibility

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Diagnostic Techniques

Source

Identifiers

PMID: 32888355
DOI: 10.1111/ejh.13513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation sequencing in hypoplastic bone marrow failure: What difference does it make?PMID 32888355Read ↗

Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomics.Semantic proximity Read ↗

Impact of next generation sequencing results on clinical management in patients with hematological disorders.Semantic proximity Read ↗

Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromesSemantic proximity Read ↗

Genomic insights into inherited bone marrow failure syndromes in a Korean population.Semantic proximity Read ↗

Targeted next generation sequencing panel based screening and diagnosis of bone marrow failure cohort reveals diverse genomic landscape of pathogenic germline variantsSemantic proximity Read ↗

Applications of high-throughput DNA sequencing to benign hematologySemantic proximity Read ↗

Lessons from next-generation sequencing analysis in hematological malignanciesSemantic proximity Read ↗

A landscape of germ line mutations in a cohort of inherited bone marrow failure patientsSemantic proximity Read ↗

Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure SyndromesSemantic proximity Read ↗

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-upSemantic proximity Read ↗

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useSemantic proximity Read ↗

Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic DiversitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.